Petvivo Holdings, Inc. (PETV) Stock Price & Analysis

Petvivo Holdings, Inc. (PETV) fell 10.29% to USD 0.61 as of September 8, 2026 at 16:13 UTC, according to Nexqual real-time market data.

PETV last closed at USD 0.61; the session ranged USD 0.61–0.68 on volume of 2,000 shares. Market capitalization is —, with a 52-week range of USD 0.59–1.69 (OQX). Source: Nexqual, September 8, 2026 at 16:13 UTC.

Key Statistics (as of September 8, 2026 at 16:13 UTC)

Technical Analysis (PETV)

Nexqual's technical model rates PETV "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 16:13 UTC.

From Petvivo Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-06-29)

Key Strengths & Strategy (as disclosed to the SEC)

• In addition, the FDA and other U.S. regulatory bodies (including the Federal Trade Commission, the Office of the Inspector General of the Department of Health and Human Services, the Department of Justice (DOJ), and various state Attorneys General) monitor the manner in which we promote and advertise our products.
• In addition to the United States patent portfolio, we also have four patents granted in key markets around the world including Canada and countries within the European Union.   We believe we have developed a broad and deep patent portfolio around our biomaterials and manufacturing processes in addition to the application of these biomaterials for use as medical devices, medical device coatings, and pharmaceutical delivery devices.
• We believe our intellectual property portfolio strongly protects our proprietary technology, including the composition of raw elements used to produce our formulations, the fabricated biomaterials, and their application in end products, thereby making our material and devices much more attractive to industry partners.   Furthermore, we rely on proprietary trade secrets and confidential know-how to protect various aspects of its product formulations and manufacturing processes.
• We also strenuously protect our proprietary information and proprietary technology through a combination of contractual arrangements, trade secrets, and patents, both in the United States and abroad.

Partnerships

• In December 2023, the Company entered into a non-exclusive distribution agreement with Covetrus North America, LLC ("Covetrus Distribution Agreement"), to market, distribute and sell the Company's products in the United States, including the District of Columbia.
• In March 2025, we mutually terminated our non-exclusive distribution agreement with MWI.   We entered into a Distribution Services Agreement (the "Agreement") with Covetrus on December 18, 2023.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:13 UTC. This page is informational and not investment advice.